NeoGenomics’ Pharma Services offer two multiplex immunofluorescence platforms: MultiOmyx™ and Vectra® Polaris™
MultiOmyx™ is a proprietary, high-order multiplexing methodology that enables visualization and characterization of up to 60 proteins in a single FFPE tissue section.
High order ≥ 7 plex
Comprehensive analysis of tumor biology
Deep & precise immuno-profiling
Vectra® Polaris™ is an automated system that allows simultaneous detection of 2-6 different markers from a single FFPE tissue slide which would provide a streamlined workflow for implementing refined low-order multiplex panel sets.
Low order 2-6 plex
High-throughput & faster TAT
Assay transfer & validation
Quantitation of CD137 and Nectin-4 expression across multiple tumor types to support indication selection for BT7480, a Bicycle TICA
Multiplex Immunofluorescence Assay, MultiOmyx: Detection and deep profiling of immune cells in HBV-infected liver biopsies
Co-detection of a tumor-infiltrating lymphocyte immunofluorescence (IF) panel and cytokine RNA in-situ hybridization (ISH) markers in non-small cell lung cancer (NSCLC) tumor microenvironment using combined MultiOmyx and RNAScope platforms
Contact Us To Get Started!
Work with us – your premier oncology partner – to optimize cancer care for patients